![](/img/cover-not-exists.png)
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-Weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-Year-Olds
Gantz, Ira, Sokolova, Liubov, Jain, Lokesh, Iredale, Carol, O'Neill, Edward A., Wei, Ziwen, Lam, Raymond, Suryawanshi, Shailaja, Kaufman, Keith D., Engel, Samuel S., Lai, EsengLanguage:
english
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2017.08.009
Date:
September, 2017
File:
PDF, 428 KB
english, 2017